Visualitza per autor "GARRALDA, Elena"
Ara mostrant els elements 1-20 d 21
-
A first-in-human phase I study of the PD-1 inhibitor, retifanlimab (INCMGA00012), in patients with advanced solid tumors (POD1UM-101)
Lakhani, Nehal; Cosman, Rasha; Banerji, Udai; Rasco, D.; Tomaszewska-Kiecana, Monika; GARRALDA, Elena (Elsevier, 2024-04) -
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
Bareche, Yacine; Abbas-Aghababazadeh, Farnoosh; Lo Giacco, Deborah; Martin Casado, Agatha; Saavedra Gadea, Omar; Berche, Roger; Mirallas, Oriol; Jimenez, Jose; Valverde Morales, Claudia Maria; Díez García, Marc; Hernando-Calvo, Alberto; Vila-Casadesús, Maria; Gonzalez Medina, Alberto; Brana, Irene; Vieito , Maria; fasani, roberta; Mancuso, Francesco Mattia; Saoudi Gonzalez, Nadia; Suárez, Cristina; Elez, Elena; Capdevila Castillon, Jaume; OAKNIN, ANA; Saura Manich, Cristina; Macarulla, Teresa; Carles, Joan; FELIP, ENRIQUETA; Nuciforo, Paolo; Seoane, Joan; Tabernero, Josep; GARRALDA, Elena; Vivancos, Ana; MUÑOZ COUSELO, EVA; Dienstmann, Rodrigo (Elsevier, 2023-10-13) -
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Lin, Chia-Chi; Hong, David S.; Martin, Miguel; GARRALDA, Elena; Siu, Lillian; Schoffski, Patrick (Taylor & Francis, 2024) -
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors
Schram, Alison; Schwartz, Gary K; Yuen, Eunice; McNeely, Samuel C; GARRALDA, Elena; Bedard, Philippe (Oxford University Press, 2024-01) -
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors
Hanna, Glenn; Stathis, Anastasios; López Miranda, Elena ; Racca Bussano, Fabricio; Quon, Doris; Leyvraz, Serge; GARRALDA, Elena (American Association for Cancer Research, 2023-09-14) -
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer
Van Cutsem, Eric; GARRALDA, Elena; Tai, David; de Braud, Filippo Guglielmo Maria; Geva, Ravit; Elez, Elena ; Tabernero, Josep (Oxford University Press, 2023-03) -
A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?
Gielen, Bente; Cresta Morgado, Pablo; Prior, Olivia; Ligero, Marta; Navarro Garces, Victor; Dienstmann, Rodrigo; Nuciforo, Paolo; GARRALDA, Elena; Perez-Lopez, Raquel (Nature Portfolio, 2024-02-21) -
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial
Kim, Tae Won; LoRusso, Patricia; Gordon, Michael; Bendell, Johanna ; OH, DO-YOUN; Bedard, Philippe; GARRALDA, Elena (American Medical Association, 2023-11) -
Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors
Robbrecht, Debbie; Grob, Jean-Jacques; Bechter, Oliver; Simonelli, Matteo; Doger, B.; Borbath, Ivan; Doger, B; GARRALDA, Elena (Wiley, 2024-02) -
Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey
Linardou, Helena; Adjei, A. A.; Bajpai, J.; Banerjee, Susana; Berghoff, Anna Sophie; Cerqueira Mathias, C.; GARRALDA, Elena; FELIP, ENRIQUETA (Elsevier, 2023-04) -
Drug Cost Avoidance Resulting from Participation in Clinical Trials: A 10-Year Retrospective Analysis of Cancer Patients with Solid Tumors
Valdivia Vadell, Carolina; Farriols Danés A, Farriols A; Mañós, Laura; Vidal Otero, Jana; Alcalde Rodrigo, Maria; De la Paz, Isabel; Palacio-Lacambra, Maria-Eugenia; Sabaté Augé, Núria; Garau Gomila, Margarita; Carreras Soler, Maria Josep; Renedo-Miró, Berta; Tomás-Guillén, Elena; JIMENEZ LOZANO, INES; FELIP, ENRIQUETA; GARRALDA, Elena; Gorgas, Maria Queralt; Tabernero, Josep (MDPI, 2024-04-17) -
Engaging European society at the forefront of cancer research and care
Celis, Julio E; Ringborg, Ulrik; heitor, manuel; Berns, Anton; Albreht, Tit; GARRALDA, Elena; Baumann, Michael (Wiley, 2023-06) -
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
Lozano Rabella, Maria; Garcia-Garijo, Andrea; Palomero, Jara; Yuste-Estevanez, Anna; Erhard, Florian; Farriol-Duran, Roc; Ochoa de Olza, Maria; Matos, Ignacio ; Canals, Francesc; Brana, Irene; Gros, Alena; GARRALDA, Elena; MUÑOZ COUSELO, EVA (American Association for Cancer Research, 2023-06-13) -
MYC targeting by OMO-103 in solid tumors: a phase 1 trial
Moreno, Victor; Martínez Martín, Sandra; Alonso-Casal, Guzman; Arqués, Oriol; GARRALDA, Elena; Beaulieu, Marie-Eve; Casacuberta-Serra, Sílvia; Foradada Felip, Laia; Perez-Lopez, Raquel; Whitfield, Jonathan; Soucek, Laura (Nature Portfolio, 2024-02-06) -
Patient-Centric Approaches for Phase I Combination Trials Come on Stage
Hernando-Calvo, Alberto; GARRALDA, Elena (American Association for Cancer Research, 2023-08-04) -
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors
Joerger, Markus; Calvo, Emiliano; Laubli, Heinz; Lopez, Juanita; Alonso-Casal, Guzman; Corral de la Fuente, Elena; GARRALDA, Elena (BMJ, 2023-11) -
Pralsetinib in patients with RET fusion–positive non-small-cell lung cancer: A plain language summary of the ARROW study
Griesinger, Frank; Baik, Christina; Tan, Daniel; Lee, Dae Ho; Curigliano, Giuseppe; Subbiah, Vivek; GARRALDA, Elena (Future Medicine, 2024-02) -
Public and patient involvement: a survey on knowledge, experience and opinions among researchers within a precision oncology European project
Mosconi, Paola; COLOMBO, CINZIA; Paletta, Pasquale; Gangeri, Laura; Pellegrini, Chiara; GARRALDA, Elena (BMC, 2023-08-30) -
Towards evidence-based response criteria for cancer immunotherapy
Laurie, Scott; Seymour, Lesley; de Vries, Elisabeth; GARRALDA, Elena (Nature Portfolio, 2023-05-24) -
Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein
Kroenke, Mark; Starcevic Manning, Marta; de Zafra, Christina; Zhang, Xinwen; Cook, Kevin; Archer, Michael; GARRALDA, Elena (Frontiers Media, 2024-01-26)